Results 1 - 10 of 84

< 1 2 3 ... 8 9 >

• Blair et al.. Structure-guided development of affinity probes for tyrosine kinases using chemical genetics, Nature Chemical Biology, 2007

  [DOI: 10.1038/nchembio866]
  
• Shannon E. Telesco, Andrew J. Shih, Fei Jia and Ravi Radhakrishnan. A multiscale modeling approach to investigate molecular mechanisms of pseudokinase activation and drug resistance in the HER3/ErbB3 receptor tyrosine kinase signaling network, Mol. Biosyst., 2011, 7, 2066.

  [DOI: 10.1039/c0mb00345j]
  
• Jingxian ZhangThe authors contributed equally to this work., Jia Jia, Feng Zhu, Xiaohua Ma, Bucong Han, Xiaona Wei, Chunyan Tan, Yuyang Jiang and Yuzong Chen. Analysis of bypass signaling in EGFR pathway and profiling of bypass genes for predicting response to anticancer EGFR tyrosine kinase inhibitors, Mol. Biosyst., 2012, 8, 2645.

  [DOI: 10.1039/c2mb25165e]
  
• Bing Wang, Chunlei Zhu, Libing Liu, Fengting Lv, Qiong Yang and Shu Wang. Synthesis of a new conjugated polymer for cell membrane imaging by using an intracellular targeting strategy, Polym. Chem., 2013, .

  [DOI: 10.1039/c3py00097d]
  
• Woodring Jennifer L., Patel Gautam, Erath Jessey, Behera Ranjan, Lee Patricia J., Leed Susan E., Rodriguez Ana, Sciotti Richard J., Mensa-Wilmot Kojo, Pollastri Michael P.. Evaluation of aromatic 6-substituted thienopyrimidines as scaffolds against parasites that cause trypanosomiasis, leishmaniasis, and malaria, Med. Chem. Commun., 2014

  [DOI: 10.1039/C4MD00441H]
  
• Sun Chiyu, Li Yangsheng, Shi Ailong, Zhang Jingzhou, Li Yafei, Zhao Mingming, Zhang Lijuan, Zheng Huachuan, Meng Ying, Ding Huaiwei, Song Hongrui. Synthesis and evaluation of novel N-3-benzimidazolephenylbisamide derivatives for antiproliferative and Hedgehog pathway inhibitory activity, Med. Chem. Commun., 2015

  [DOI: 10.1039/C5MD00092K]
  
• Kaczy?ska A; Herman-Antosiewicz A. Combination of lapatinib with isothiocyanates overcomes drug resistance and inhibits migration of HER2 positive breast cancer cells., Breast cancer (Tokyo, Japan)

  [PubMed: 27154770]
  [DOI: 10.1007/s12282-016-0700-9]
  
• Report of safety of pulse dosing of lapatinib with temozolomide and radiation therapy for newly-diagnosed glioblastoma in a pilot phase II study, Journal of Neuro-Oncology

  [DOI: 10.1007/s11060-017-2533-6]
  
• The Dual-Targeted HER1/HER2 Tyrosine Kinase Inhibitor Lapatinib Strongly Potentiates the Cardiac Myocyte-Damaging Effects of Doxorubicin, Cardiovascular Toxicology

  [DOI: 10.1007/s12012-012-9183-x]
  
• Lapatinib: New Directions in HER2 Directed Therapy for Early Stage Breast Cancer, Adjuvant Therapy for Breast Cancer

  [DOI: 10.1007/978-0-387-75115-3_13]